Table 3.
Pharmacokinetic parameters of paraxanthine after administration of 15 mg/kg caffeine intravenously in the. presence and absence of rutaecarpine in rats. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
| Paraxanthine (IV caffeine) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Parameter | AUCINF (μg.h/mL) | Tmax (h) | MRTinf (h) | T 1/2 (h) | AUCm/AUCp | |||||
| Control | 21.571 ± 2.743 | % of control | 4.667 ± 1.15 | % of control | 5.03 ± 0.43 | % of control | 1.349 ± 0.09 | % of control | 0.74 ± 0.04 | % of control |
| 3 h | 8.31 ± 0.72**** | 39% | 2.67 ± 1.15* | 57% | 2.85 ± 0.28**** | 57% | 0.47 ± 0.10**** | 35% | 0.54 ± 0.03** | 73% |
| 6 h | 6.17 ± 0.59**** | 29% | 2.0 ± 0.00** | 43% | 2.57 ± 0.27**** | 51% | 0.82 ± 0.07** | 61% | 0.51 ± 0.04** | 69% |
| 12 h | 3.86 ± 1.30**** | 18% | 1.0 ± 0.00*** | 21% | 1.28 ± 0.212**** | 25% | 0.49 ± 0.24**** | 37% | 0.42 ± 0.13*** | 57% |